Identification of a novel peptide derived from the melanocyte-specific gp100 antigen as the dominant epitope recognized by an HLA-A2.1-restricted anti-melanoma CTL line.

Bakker, A B; Schreurs, M W; Tafazzul, G; de Boer, A J; Kawakami, Y; Adema, G J; Figdor, C G

Bakker, A B; Schreurs, M W; Tafazzul, G; de Boer, A J; Kawakami, Y; Adema, G J; Figdor, C G.

Affiliation

Bakker AB; Department of Tumor Immunology, University Hospital Nijmegen St. Radboud, The Netherlands.

Int J Cancer ; 62(1): 97-102, 1995 Jul 04.

Article in En | MEDLINE | ID: mdl-7541395

Subject(s)

Epitopes; HLA-A Antigens/analysis; Melanoma/immunology; Membrane Glycoproteins/immunology; Neoplasm Proteins/immunology; T-Lymphocytes, Cytotoxic/immunology; Amino Acid Sequence; Base Sequence; Humans; Membrane Glycoproteins/analysis; Molecular Sequence Data; Neoplasm Proteins/analysis; Peptide Fragments/immunology; Tumor Cells, Cultured; gp100 Melanoma Antigen

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Membrane Glycoproteins / T-Lymphocytes, Cytotoxic / HLA-A Antigens / Melanoma / Epitopes / Neoplasm Proteins Type of study: Diagnostic_studies / Guideline Limits: Humans Language: En Journal: Int J Cancer Year: 1995 Document type: Article Affiliation country: Netherlands Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links